Please assess the completion status of the following clinical trial:

Trial Title: Epinephrine Sprayed on the Papilla Versus Sterile Water Sprayed on the Papilla for Preventing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18 years or older~* Patient with an indication for endoscopic retrograde cholangiopancreatography~* Patient without prior endoscopic retrograde cholangiopancreatography~* Patient who accept contact by telephone~Exclusion Criteria:~* Previous sphincterotomy~* Allergy to epinephrine or indomethacin~* NSAIDs use in the prior week~* Pancreatic cancer located in the head~* Chronic pancreatitis~* Renal failure (Cr \>1.4 mg / dl)~* Indication for endotracheal intubation independent of endoscopic retrograde cholangiopancreatography~* Biliodigestive derivation~* Pregnant patients

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- Epinephrine sprayed on the papilla and rectal indomethacin (Type: ACTIVE_COMPARATOR): Epinephrine 1 mg/1 mL + 9 mL of sterile water are sprayed on the papilla at the end of the endoscopic retrograde cholangiopancreatography and 100 mg of indomethacin rectal suppository is administered at the beginning of the procedure
- Sterile water sprayed on the papilla and rectal indomethacin (Type: PLACEBO_COMPARATOR): 10 mL of sterile water are sprayed on the papilla at the end of the endoscopic retrograde cholangiopancreatography and 100 mg of indomethacin rectal suppository is administered at the beginning of the procedure

Based on this trial design, predict the completion outcome and termination type (if applicable).